Related Publications - MORAb-004
MORAb-004 is a humanized IgG1 monoclonal antibody that recognizes a cell surface protein, endosialin, also called Tumor Endothelial Marker-1 (TEM1) and CD248, which is expressed on tumor associated pericytes, tumor stromal cells and directly on a subset of malignant cells.
- Morphotek, Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, A Monoclonal Antibody for the Treatment of Cancer
- Research Uncovers Molecular Function of Endosialin Target of MORAb-004, Anti-Angiogenic Antibody Being Evaluated for Cancer, Neovascular Disease